Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Timing of Primaquine for Malaria Transmission
NCT01906788Phase 4Unknown
- Sponsor
- Kilimanjaro Clinical Research Institute
- Start
- May 2013
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of primaquine in Falciparum malaria (PF), sponsored by Kilimanjaro Clinical Research Institute. Status: unknown.
02
Drugs
primaquine
03
Conditions
Falciparum malaria (PF)
Beyond the preview
Go deeper on NCT01906788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01906788.